We updated the design of this site on September 25th. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Oxidative Stress and Cardiac Arrest

This study has been completed.
Sponsor:
ClinicalTrials.gov Identifier:
NCT00888966
First Posted: April 28, 2009
Last Update Posted: July 4, 2011
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Information provided by:
Institut d'Anesthesiologie des Alpes Maritimes
  Purpose

Cardiac arrest is a major health problem reaching 375000 cases in Europe each year. Only 5 to 31 % survive after an out of hospital cardiac arrest (OHCA). The main complication after OHCA is the anoxic encephalopathy. Recently mild hypothermia has shown a beneficial effect on survival. But the mechanisms underlying these therapy are not clear.

Cardiac arrest is an example of ischemia reperfusion of the entire body. And it is well demonstrated that reperfusion generates an oxidative stress. But it has never been shown in a clinical setting.

The aim of the study is to evaluate oxidative stress after out of hospital cardiac arrest treated with mild hypothermia.


Condition
Heart Arrest

Study Type: Observational
Study Design: Observational Model: Cohort
Time Perspective: Prospective
Official Title: Evaluation of Oxidative Stress After Out of Hospital Cardiac Arrest Treated With Moderate Hypothermia

Resource links provided by NLM:


Further study details as provided by Institut d'Anesthesiologie des Alpes Maritimes:

Primary Outcome Measures:
  • Oxidative stress markers and antioxidants after out of hospital cardiac arrest [ Time Frame: 4 days ]

Secondary Outcome Measures:
  • Lactate after out of hospital cardiac arrest [ Time Frame: 4 days ]
  • Outcome after out of hospital cardiac arrest [ Time Frame: 6 months ]

Biospecimen Retention:   Samples Without DNA
Plasma

Estimated Enrollment: 40
Study Start Date: April 2006
Study Completion Date: December 2010
Primary Completion Date: June 2010 (Final data collection date for primary outcome measure)
Groups/Cohorts
Out of hospital cardiac arrest
Out of hospital cardiac patients successfully resuscitated and admitted to ICU

  Eligibility

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   18 Years to 80 Years   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
community sample
Criteria

Inclusion Criteria:

  • Out of hospital cardiac arrest

Exclusion Criteria:

  • refractory shock
  • moribund patient
  • resuscitation > 60 minutes
  • hypothermia < 30 degrees
  Contacts and Locations
Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00888966


Locations
France
CHU de Nice
Nice, France, 06003
Sponsors and Collaborators
Institut d'Anesthesiologie des Alpes Maritimes
Investigators
Study Chair: Carole Ichai, MD, PhD CHU de Nice
  More Information

Responsible Party: Orban MD, CHU de Nice
ClinicalTrials.gov Identifier: NCT00888966     History of Changes
Other Study ID Numbers: IAAM 2009-2
First Submitted: April 25, 2009
First Posted: April 28, 2009
Last Update Posted: July 4, 2011
Last Verified: June 2011

Keywords provided by Institut d'Anesthesiologie des Alpes Maritimes:
heart arrest
oxidative stress
lactic acid
outcome

Additional relevant MeSH terms:
Heart Arrest
Out-of-Hospital Cardiac Arrest
Heart Diseases
Cardiovascular Diseases


To Top